Skip to main content
Clinical Trials/NCT05442307
NCT05442307UnknownNot Applicable

Boosting General Practice pRescription by Individual Educational Fast Academic Detailing Visits About Asthma

University Hospital Bispebjerg and Frederiksberg2 sites in 1 country360 target enrollmentStarted: October 6, 2021Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Sponsor
Enrollment
360
Locations
2
Primary Endpoint
Difference in change of prescription of inhaled corticosteroids and long-acting beta2-agonist (ICS+LABA) before and after educational visit in a six months period

Study Overview

Brief Summary

General practices in the Capital Region of Denmark are offered a short educational visit and are randomized to either asthma (intervention) or another topic (control).

The change in prescription pattern from before to after the visit is compared between the intervention and control group.

Detailed Description

General practices in the Capital Region of Denmark are offered a short educational visit. They are randomized by address to be offered a visit about either asthma (intervention) or another topic (control).

The prescription pattern of each general practice (as seen by their regional registration number [ydernummer]) who receive a visit is investigated.

The change in prescription pattern from before to after the visit is compared between the intervention and control group.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Health Services Research
Masking
None

Eligibility Criteria

Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • General practices in the capital region of denmark, who owns a regional registration number [ydernummer]
  • Want a visit
  • Have time for a visit within the study period

Exclusion Criteria

  • Not provided

Arms & Interventions

Other education

Placebo Comparator

The general practices in this arm will receive an educational visit on another topic (PPI).

Intervention: Other education (Behavioral)

asthma education

Experimental

The general practices in this arm will receive the education visits about asthma.

Intervention: asthma education (Behavioral)

Outcomes

Primary Outcomes

Difference in change of prescription of inhaled corticosteroids and long-acting beta2-agonist (ICS+LABA) before and after educational visit in a six months period

Time Frame: 6-0 months before and 6-12 months after educational visit

Difference in change of number of adult patients with prescriptions on ICS+LABA between asthma-group and placebo-group.

Difference in change of prescription of ICS and SABA (as monotherapy) before and after educational visit in a six months period

Time Frame: 6-0 months before and 6-12 months after educational visit

Difference in change of number of adult patients with prescriptions on ICS and SABA as monotherapy to adults between asthma-group and placebo-group.

Secondary Outcomes

  • Difference in change of prescription of ICS+LABA before and after educational visit in one year(one year before and one year after educational visit)
  • Difference in change of prescription of LAMA before and after educational visit in one year(one year before and one year after educational visit)
  • Difference in change of prescription of ICS+LABA before and after educational visit in one year as interrupted time series analysis(one year before and one year after educational visit)
  • Difference in change of prescription of the Easyhaler Device before and after educational visit in a six months period(6-0 months before and 6-12 months after educational visit)
  • Difference in change of prescription of ICS and SABA (as monotherapy) before and after educational visit one year as interrupted time series analysis(one year before and one year after educational visit)
  • Difference in change of prescription of the Easyhaler Device before and after educational visit in one year(one year before and one year after educational visit)
  • Difference in change of prescription of long-acting muscarinic antagonist (LAMA) before and after educational visit in a six months period(6-0 months before and 6-12 months after educational visit)
  • Difference in change of prescription of LAMA before and after educational visit as interrupted time series analysis(one year before and one year after educational visit)
  • Difference in change of prescription of ICS and SABA (as monotherapy) before and after educational visit one year(one year before and one year after educational visit)
  • Difference in change of prescription of the Easyhaler Device before and after educational visit for each month(one year before and one year after educational visit)
  • Difference in change of prescription of ICS+LABA before and after educational visit in one year for each month(one year before and one year after educational visit)
  • Difference in change of prescription of ICS and SABA (as monotherapy) before and after educational visit one year for each month(one year before and one year after educational visit)
  • Difference in change of prescription of the Easyhaler Device before and after educational visit as interrupted time series analysis(one year before and one year after educational visit)
  • Difference in change of prescription of LAMA before and after educational visit for each month(one year before and one year after educational visit)
  • Difference in change of cost of each medication group before and after educational visit in a six months period(6-0 months before and 6-12 months after educational visit)
  • Difference in change of cost of each medication group before and after educational visit for each month(one year before and one year after educational visit)
  • Difference in change of cost of each medication group before and after educational visit in one year(one year before and one year after educational visit)
  • Difference in change of cost of each medication group before and after educational visit as interrupted time series analysis(one year before and one year after educational visit)

Investigators

Sponsor
University Hospital Bispebjerg and Frederiksberg
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Jón Þór Trærup Andersen

MD

University Hospital Bispebjerg and Frederiksberg

Study Sites (2)

Loading locations...

Similar Trials